SEBI Reg. Investment Advisor

Download App
Help Center Subscribe
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

KRM Ayurveda Ltd (KRMAYURVED)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: KRMAYURVED Hospital & Healthcare Services | Small Cap | KRM Ayurveda Share Price

BSE Share Price
Not Listed

KRM Ayurveda Ltd (KRMAYURVED)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: KRMAYURVED Hospital & Healthcare Services | Small Cap | KRM Ayurveda Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹565 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹9.5
TTM Sales
₹102 Cr.
Book Value per Share
₹21.2
P/E Ratio
28.08
Lower than its 5-year historical median
Industry PE
91.4
Price to Book (P/B)
12.56
Higher than its 5-year historical median
Price to Sales (P/S)
5.56
In line with its 5-year historical median
EV/EBITDA
19.09
Lower than its 5-year historical median
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
67.86%
Outperforms industry median
Return on Capital Employed (ROCE)
41.83%
Outperforms industry median
Return on Assets (ROA)
21.86%
Operating Profit Margin
25.4%
Net Profit Margin
15.8%
Gross Profit Margin
22.7%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
13.98%
Operating Profit Growth (1 Year)
-
155.98%
Net Profit Growth (1 Year)
-
254.84%
Asset Quality
Promoter Holding
69.15%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹24 Cr.
Equity
₹21.3 Cr.
Face Value
₹10
All Time Low / High
- / -

KRM Ayurveda stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is KRM Ayurveda Ltd a good quality company?
KRM Ayurveda Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does KRM Ayurveda Ltd performance compare with that of its Peers?
Q.1 Revenue growth of KRM Ayurveda Ltd vs industry peers?
KRM Ayurveda Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 6.53%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of KRM Ayurveda Ltd?
Promoters hold 69.15% of the KRM Ayurveda Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of KRM Ayurveda Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.
View More

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
KRM Ayurveda Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'23Mar'24Mar'25TTM
ROCE % ⓘ37.7%22.2%41.8%-
Value Creation
Index ⓘ		1.70.62.0-

Growth Parameters ⓘ
Sales ⓘ89.367.276.6102
Sales YoY Gr.--24.8%14%-
Adj EPS ⓘ5.12.38.19.5
YoY Gr.--55.2%255.1%-
BVPS (₹) ⓘ5.67.915.921.2
Adj Net
Profit ⓘ		7.63.412.120
Cash Flow from Ops. ⓘ3.5-0.9-0-
Debt/CF from Ops. ⓘ5.7-25.9-1090.9-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNANANA14%
Adj EPS ⓘNANANA255.1%
BVPSⓘNANANA102.8%
Share Price - - - -

Key Financial Parameters ⓘ

Mar'23Mar'24Mar'25TTM
Return on
Equity % ⓘ		90.833.967.951
Op. Profit
Mgn % ⓘ		12.511.325.4NAN
Net Profit
Mgn % ⓘ		8.55.115.819.8
Debt to
Equity ⓘ		2.421.3-
Working Cap
Days ⓘ		0991400
Cash Conv.
Cycle ⓘ		0-7160

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'23Mar'24Mar'25
Sales896777
Operating Expenses ⓘ + 786057
Manufacturing Costs222
Material Costs191010
Employee Cost 181917
Other Costs ⓘ 392928
Operating Profit ⓘ 11819
Operating Profit Margin (%) 12.5%11.3%25.4%
Other Income ⓘ + 000
Exceptional Items ⓘ 000
Interest ⓘ 122
Depreciation ⓘ 111
Profit Before Tax ⓘ 10516
Tax ⓘ 214
Profit After Tax 8312
PAT Margin (%) 8.5%5.1%15.8%
Adjusted EPS (₹)5.12.38.1
Dividend Payout Ratio (%)0%0%0%

Valuation of KRM Ayurveda - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 81224
Share Capital ⓘ 000
Reserves ⓘ 81224
Debt +182129
Long Term Debt182119
Short Term Debt1111
Minority Interest000
Trade Payables545
Others Liabilities ⓘ 878
Total Liabilities ⓘ 394467

Fixed Assets

Net Fixed Assets ⓘ +232327
Gross Block252530
Accumulated Depreciation123
CWIP ⓘ 000
Investments ⓘ 000
Inventories118
Trade Receivables8612
Cash Equivalents 012
Others Assets ⓘ 71418
Total Assets ⓘ 394467

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'23Mar'24Mar'25
Cash Flow From Operating Activity ⓘ + 4-1-0
PBT ⓘ 10516
Adjustment ⓘ 133
Changes in Working Capital ⓘ -7-5-16
Tax Paid ⓘ -1-3-3
Cash Flow From Investing Activity ⓘ + -23-0-4
Capex -23-1-5
Net Investments 000
Others ⓘ 000
Cash Flow From Financing Activity ⓘ + 1916
Net Proceeds from Shares ⓘ 000
Net Proceeds from Borrowing ⓘ 183-2
Interest Paid ⓘ -0-2-2
Dividend Paid ⓘ 000
Others ⓘ 2010
Net Cash Flow ⓘ 002

Financial Ratio

PARTICULARSMar'23Mar'24Mar'25
Ratios
ROE (%)90.8233.8867.86
ROCE (%)37.6722.1741.83
Asset Turnover Ratio2.261.611.38
PAT to CFO Conversion(x)0.5-0.33-0
Working Capital Days
Receivable Days31.7036.1042.10
Inventory Days2.805.8021.80
Payable Days100.30163.50176.70

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

KRM Ayurveda Ltd FAQs

The current trading price of KRM Ayurveda on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of KRM Ayurveda stood at ₹564.9 Cr

The latest P/E ratio of KRM Ayurveda as of 31-Dec-1969 is 28.08.

The latest P/B ratio of KRM Ayurveda as of 31-Dec-1969 is 12.56.

The 52-week high of KRM Ayurveda is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of KRM Ayurveda is ₹102 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that KRM Ayurveda Ltd is a below average quality company.

The key valuation ratios of KRM Ayurveda Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of KRM Ayurveda Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About KRM Ayurveda Ltd

KRM Ayurveda was incorporated as a Private Limited Company under the name of ‘KRM Ayurveda Private Limited’ on September 03, 2019. Further, the company was converted into a Public Limited Company in pursuance of a special resolution passed by the members of the company at the Extra Ordinary General Meeting held on November 23, 2024 and the name of the company was changed from ‘KRM Ayurveda Private Limited’ to ‘KRM Ayurveda Limited’ on December 24, 2024.

The company is operating a network of hospitals and clinics across multiple cities in India as well as marked its presence in abroad through telemedicines consulting and sales. Though the company started off as a kidney hospital and it continues to provide specialized treatment for kidney disorders, the company has widened its horizons in the past few years and has now evolved for various health disorders such as kidney disorder, Liver Cirrhosis, Diabetes, Fatty Liver, Arthritis etc. The company has marked its reach globally as well through Tele-Consultancy Services. Further, it focuses on specialized segments within the medical and healthcare domain that address specific health issues and challenges, such as addiction, personal care, wellness, and related areas and for that it is engaged into trading of Ayurvedic medicine, oils and supplements.

The company’s Hospitals and Clinics are equipped with the following infrastructure & facilities: Beds, including general wards and premium rooms, Panchakarma treatment units, Herbal pharmacy and medicine preparation unit, Ayurvedic diet kitchen, Consultation chambers for Vaidyas (Ayurvedic physicians), and in-house yoga and meditation hall. The company is also engaged in the processing, formulation, and marketing of portfolio of Ayurvedic therapeutic and wellness products. Its product portfolio is primarily focused on addressing chronic lifestyle and metabolic disorders. The company markets its products through its network of hospitals and clinics and also provides patient access through an integrated telemedicine service, enabling remote consultations and product delivery. Its product is based on classical Ayurvedic formulations, standardized herbal extracts, controlled processing methods, and quality-assurance protocols.

Business area of the company

The company operates multi-specialty hospitals and clinics at various locations in the country. The company is also engaged in development and sale of Ayurvedic products. Further, it focuses on specialized segments within the medical and healthcare domain that address specific health issues and challenges, such as addiction, personal care, wellness, and related areas and for that it is engaged into trading of Ayurvedic medicine, oils and supplements.

Products and services of the company

  • In-Patient & Out-Patient Care: Treatment for chronic diseases, lifestyle disorders, and post-operative rehabilitation.
  • Panchakarma Therapies: Detoxification and rejuvenation programs.
  • Specialized Clinics: Orthopedic care, skin and hair care, women’s wellness, geriatric care.
  • Wellness Packages: Stress management, weight management, preventive health plans.
  • Diet & Lifestyle Counseling: Personalized nutrition and yoga consultation.
  • Medicinal Sales: Dispensary of in-house and certified Ayurvedic medicines.

History and milestones

  • 2022: Received NABH Accreditations for Gurgaon Hospital.
  • 2023: Received NABH Accreditations for Delhi Hospital.
  • 2023: Received approval from Ayush Ministry to manufacture Ayurvedic Medicines.
  • 2023: Received ECHS Empanelment.
  • 2024: Received CGHS Empanelment.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: